Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04147832 · ClinicalTrials.gov registry record
Epividian / AHF: Positive Pathways - HIV Retention in Care
A clinical trial, sponsored by Epividian.
- Completed
- Registry status
- 10,521
- Enrollment target
NCT04147832: Completed study, sponsored by Epividian.
NCT04147832 is a clinical trial that has completed, run by Epividian. The registered enrollment target is 10,521 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04147832 has completed, sponsored by Epividian.
- COMPLETED
- Registry status
- 10,521 participants
- Enrollment target
Study Summary
The primary objective of this study is to evaluate the effectiveness of a clinical decision support system (CDSS) combined with enhanced patient contact to retain HIV+ patients in care with AIDS Healthcare Foundation. Specifically, the study aims to evaluate the effectiveness of having the patient's primary caregiver (or dedicated case manager) telephone the patient when the patient is identified as a significant risk to loss of follow-up (at-risk patients) based upon pre-defined criteria. The secondary objective Gain a better understanding about the implementation of the study's procedures in clinical practice by evaluating survey responses delivered to participating healthcare providers and AHF staff members engaging with the study's intervention.
Primary Outcome
Pre and post-baseline rate of patients who attended their scheduled office visits.
Interventions
- OTHER Alert to provider
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,521 participants |
| Start Date | 2020-10-05 |
| Est. Completion | 2021-07-31 |
What the finished NCT04147832 record still lists
NCT04147832 is an observational study that tracks outcomes without assigning an intervention. Its 10,521 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Alert to provider is the first listed.
NCT04147832 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04147832 about?
NCT04147832 is a clinical study titled "Epividian / AHF: Positive Pathways - HIV Retention in Care". The primary objective of this study is to evaluate the effectiveness of a clinical decision support system (CDSS) combined with enhanced patient contact to retain HIV+ patients in care with AIDS Healthcare Foundation. Specifically, the study aims to evaluate the effectiveness of having the patient's...
What is the current status of trial NCT04147832?
This trial is currently completed. The enrollment target is 10,521 participants. The study started on 2020-10-05. Estimated completion is 2021-07-31.
What interventions are being tested in trial NCT04147832?
The interventions under investigation include: Alert to provider (OTHER).
Who is sponsoring clinical trial NCT04147832?
This trial is sponsored by Epividian, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05759299 · 10,500 participants
International obServational sTudy on AiRway manaGement in operAting Room and Non-operaTing Room anaEsthesia
- NCT06891222 · 10,500 participants
A Study of Electrocardiogram and Focused Cardiac Ultrasound for Enhanced Cardiac Disease Screening
- NCT07157774 · 10,450 participants · Phase 3
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
- NCT06081517 · 10,600 participants
Evaluating Disparities in Precision Oncology
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI